NCT05440019 (FERTIGO®) is a clinical trial of IMAGE CAPTURE SESSION in Infertility, Female, sponsored by Instituto Valenciano de Infertilidad, IVI VALENCIA.

Who is sponsoring NCT05440019?

NCT05440019 is sponsored by Instituto Valenciano de Infertilidad, IVI VALENCIA.

What drugs are being tested in NCT05440019?

Interventions in NCT05440019: IMAGE CAPTURE SESSION.

What condition does NCT05440019 study?

NCT05440019 studies Infertility, Female.

Is NCT05440019 still recruiting?

NCT05440019 is currently completed. Last updated 24 October 2023.

Last reviewed 2023-10-24 · How we verify

NCT05440019: FERTIGO®

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of the Safety and Usability of the M3T Fertigo System and Its Calibration

Completed Last updated 24 October 2023

What this trial tests

trial testing IMAGE CAPTURE SESSION in Infertility, Female in 20 participants. Completed in 26 April 2023.

Timeline

14 September 2022

Primary endpoint
26 April 2023

26 April 2023

Quick facts

Lead sponsor	Instituto Valenciano de Infertilidad, IVI VALENCIA
Status	Completed
Study type	OBSERVATIONAL
Enrollment	20
Start date	14 September 2022
Primary completion	26 April 2023
Estimated completion	26 April 2023
Sites	1 location across Spain

Drugs / interventions tested

IMAGE CAPTURE SESSION

Conditions studied

Infertility, Female — all drugs for Infertility, Female →

Sponsor

Instituto Valenciano de Infertilidad, IVI VALENCIA — full company profile →

Who can join

Adults 18 to 40, female only, with Infertility, Female. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

We have developed a new minimally invasive system for endometrial dating, that allows the physician to monitor, capture, project and analyze the actual morphology and maturity of the endometrial surface, at any given time. A time series of such indications provides an assessment regarding the pace of development by which the endometrium is maturing during a relevant cycle. FERTIGO®'s method for endometrial dating has been validated in swine and ex-vivo human samples, where image analysis of tissues has been compared with traditional endometrial dating techniques. The comparison yielded calibration means and correlation between FERTIGO®'s dating and the traditional dating methods. Thus, M3T FERTIGO®'s system is designed to enable the determination of the actual physiological cycle date, in good correlation with the indirect (endometrial thickness and hormones level) and delayed known methods (histopathology). To this end, a high quality, low magnification (X2-X4) image of the endometrium surface should be acquired, stored and analyzed. This trial will evaluate, on the one hand, the safety and usability of the FERTIGO® device and, on the other hand, calibrate it by evaluating image quality. Both safety and usability will be measured through questionnaires answered by the participants (adverse events and satisfaction) and by the physicians (satisfaction), respectively, considering the introduction of the device, its use, and its removal.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Infertility, Female

Currently open trials in the same condition.

NCT06771401 — Identification of Biomarkers in Cervical Mucus · NA · recruiting
NCT06984081 — CAPA In-vitro Oocyte Maturation · NA · recruiting
NCT07308561 — The Relationship Between Quality of Life, Anxiety Levels, and Attitudes Toward Artificial Intelligence Among Women Under · recruiting
NCT07175571 — SISTER: Sibling Oocyte Insemination With Frozen Sperm From Third Party Donors: Evaluation of Reproductive Techniques · NA · recruiting
NCT06193135 — Usefulness of Corifollitropin α as Alternative to Conventional Daily rFSH Protocols in Oocyte Donors Undergoing Pituitar · NA · recruiting

Other Instituto Valenciano de Infertilidad, IVI VALENCIA trials

Trials by the same sponsor.

NCT06193135 — Usefulness of Corifollitropin α as Alternative to Conventional Daily rFSH Protocols in Oocyte Donors Undergoing Pituitar · NA · recruiting
NCT06384794 — Study of the ZyMōt Sperm Selection Method and Its Effect on Embryo Ploidy. · NA · recruiting
NCT06103383 — Second Phase of the Pilot Study for Obtaining Mature Oocytes by in Vitro Maturation in Oocyte-donor Women · NA · unknown
NCT05161338 — Impact of Vaginal Microbiome on Vaginal Absorption of Exogenous Progesterone: a Pilot Study. · NA · completed
NCT05184777 — Evaluation of Salivary ELISA for Hormone Monitoring in IVF Patients · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05440019 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Instituto Valenciano de Infertilidad, IVI VALENCIA
Last refreshed: 24 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05440019.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing